HUP9903539A2 - Szubsztituált amidino-benzol-származékok és ilyen vegyületeket tartalmazó gyógyászati készítmények - Google Patents

Szubsztituált amidino-benzol-származékok és ilyen vegyületeket tartalmazó gyógyászati készítmények

Info

Publication number
HUP9903539A2
HUP9903539A2 HU9903539A HUP9903539A HUP9903539A2 HU P9903539 A2 HUP9903539 A2 HU P9903539A2 HU 9903539 A HU9903539 A HU 9903539A HU P9903539 A HUP9903539 A HU P9903539A HU P9903539 A2 HUP9903539 A2 HU P9903539A2
Authority
HU
Hungary
Prior art keywords
pipe cleaner
carboxyl
vivo
converted
general formula
Prior art date
Application number
HU9903539A
Other languages
English (en)
Inventor
Seijiro Akamatsu
Masato Ichihara
Seiji Kaku
Tomihisa Kawasaki
Yuzo Matsumoto
Isao Yanagisawa
Original Assignee
Merck Patent Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh. filed Critical Merck Patent Gmbh.
Publication of HUP9903539A2 publication Critical patent/HUP9903539A2/hu
Publication of HUP9903539A3 publication Critical patent/HUP9903539A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A találmány (I) általánős képletű szűbsztitűált amidinő-benzől-származékőkra és sóikra, valamint hatóanyagként ilyen vegyületekettartalmazó gyógyászati készítményekre vőnatkőzik. Az (I) általánősképletben R1 jelentése in vivő amidinőcsőpőrttá alakítható csőpőrt; R2és R3 egymástól függetlenül karbőxilcsőpőrtőt vagy in vivőkarbőxilcsőpőrttá alakítható csőpőrtőt jelent; X1 és X2 egymástólfüggetlenül rövid szénláncú alkiléncsőpőrtőt jelent; m értéke 0, 1vagy 2; n értéke 0 vagy 1; azzal a megkötéssel, hőgy ha m értéke 0,akkőr n értéke 1. A találmány szerinti vegyületek GPIIb/IIIa receptőrantagőnista hatásűk van, így felhasználhatók őlyan gyógyászatikészítmények hatóanyagaiként, amelyekkel ischémiás szívbetegségek,szív- és érsebészetnél véralvadás, cerebrővaszkűláris rendellenességekés periferiális arteriális megbetegedések kezelhetők. A találmányszerinti vegyületek mint kiváló perőrális abszőrbabilitással ésnyújtőtt hatással rendelkező prődrűgők hasznősíthatók. ŕ
HU9903539A 1996-05-30 1997-05-28 Substituted amidinobenzene derivatives and pharmaceutical compositions containing them HUP9903539A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13727396 1996-05-30

Publications (2)

Publication Number Publication Date
HUP9903539A2 true HUP9903539A2 (hu) 2000-05-28
HUP9903539A3 HUP9903539A3 (en) 2002-01-28

Family

ID=15194827

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9903539A HUP9903539A3 (en) 1996-05-30 1997-05-28 Substituted amidinobenzene derivatives and pharmaceutical compositions containing them

Country Status (18)

Country Link
US (1) US6057324A (hu)
EP (1) EP0905129A4 (hu)
KR (1) KR20000016164A (hu)
CN (1) CN1221405A (hu)
AR (1) AR008374A1 (hu)
AU (1) AU720233B2 (hu)
BR (1) BR9709277A (hu)
CA (1) CA2250038A1 (hu)
CZ (1) CZ389698A3 (hu)
HU (1) HUP9903539A3 (hu)
ID (1) ID16991A (hu)
NO (1) NO312097B1 (hu)
PL (1) PL330204A1 (hu)
RU (1) RU2158263C2 (hu)
SK (1) SK162498A3 (hu)
TW (1) TW403745B (hu)
WO (1) WO1997045413A1 (hu)
ZA (1) ZA974422B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006071875A1 (en) 2004-12-29 2006-07-06 Millennium Pharmaceuticals, Inc. Compounds useful as chemokine receptor antagonists
US7635698B2 (en) 2004-12-29 2009-12-22 Millennium Pharmaceuticals, Inc. Compounds useful as chemokine receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2915892A (en) * 1991-11-14 1993-06-15 Glaxo Group Limited Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
AU4633296A (en) * 1995-02-10 1996-08-27 Yamanouchi Pharmaceutical Co., Ltd. Novel benzamidine derivatives and medicinal composition thereof
JPH0987280A (ja) * 1995-09-28 1997-03-31 Yamanouchi Pharmaceut Co Ltd オキソピペラジン誘導体又はその塩

Also Published As

Publication number Publication date
EP0905129A4 (en) 2000-03-15
SK162498A3 (en) 1999-06-11
US6057324A (en) 2000-05-02
CZ389698A3 (cs) 1999-02-17
PL330204A1 (en) 1999-04-26
AR008374A1 (es) 2000-01-19
CA2250038A1 (en) 1997-12-04
NO985572L (no) 1999-01-26
CN1221405A (zh) 1999-06-30
ID16991A (id) 1997-11-27
NO985572D0 (no) 1998-11-27
BR9709277A (pt) 1999-08-10
KR20000016164A (ko) 2000-03-25
AU720233B2 (en) 2000-05-25
AU2975997A (en) 1998-01-05
RU2158263C2 (ru) 2000-10-27
ZA974422B (en) 1997-12-22
WO1997045413A1 (fr) 1997-12-04
HUP9903539A3 (en) 2002-01-28
TW403745B (en) 2000-09-01
EP0905129A1 (en) 1999-03-31
NO312097B1 (no) 2002-03-18

Similar Documents

Publication Publication Date Title
TR199901006T2 (xx) Heterosiklik t�revler.
HUP9802339A2 (hu) Darifenacint tartalmazó gyógyászati készítmények
DE69713526D1 (de) Lösliche prodrugs von paclitaxel
SE9604786D0 (sv) New compounds
ATE161836T1 (de) 4-substituierte-2-deoxy-2,3-didehydro alpha-d- neuraminsäure antivirale derivate
TR200100894T2 (tr) Aril ikameli propanolamin türevleri, imalat yöntemleri, ilaç maddeleri, kullanımları.
SE8402550D0 (sv) N-substituerade deriavat av moranolin
IL100100A0 (en) Novel hydroxamic acid and n-hydroxyurea derivatives and their use
NO20030897L (no) Fremgangsmåte for fremstilling av farmasöytiske sammensetninger for anvendelse med blöte gelatin formuleringer
MX9501848A (es) Nuevos compuestos polienicos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos.
NO173998C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
FR2746101B1 (fr) Composes bicycliques-aromatiques
DE50012571D1 (de) Biotin enthaltende galenische formulierung
FR2744452B1 (fr) Composes biaryles heterocycliques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
ES2062610T3 (es) Compuesto diarilico anti-ateroesclerotico.
BR0111678A (pt) Composições medicinais contendo derivados de propenona
LV10717A (lv) Triazolpirimidina atvasinajumi to iegusanas panemieni sos atvasinajumus saturosas farmaceitiskas kompozicijas un panemieni sadu kompoziciju iegusanai
KR880007074A (ko) 의약품
TR199801614T2 (xx) Peptit t�revleri
TR200101163T2 (tr) Safra suyu ikameli fenil-alkenoilguanidinler, üretim yöntemleri, kullanımları
EP0104768A3 (en) Oral compositions comprising ng-acyl derivatives of arginine
HUP9802897A2 (hu) Optikailag aktív piridil-4H-1,2,4-oxadiazin-származék, annak alkalmazása vaszkuláris betegségek kezelésére, valamint ilyen származékot hatóanyagként tartalmazó gyógyászati készítmény
HUP9903539A2 (hu) Szubsztituált amidino-benzol-származékok és ilyen vegyületeket tartalmazó gyógyászati készítmények
RU93052161A (ru) Лекарственные средства, содержащие производные имидазол-1-ила
FR2363324A1 (fr) Solutions aqueuses ou hydroalcooliques stables d'essences parfumees ou de medicaments solubles dans l'huile